Defeated Icahn sells Visx stake
This article was originally published in Clinica
Executive Summary
Laser vision correction firm Visx has finally shaken off the attentions of financier Carl Icahn, who recently failed to gain board representation with the aim of securing a buyer for the firm (see Clinica No 1059, p 13). Mr Icahn has sold an 11.8% stake in the firm, amounting to some 6 million shares.